• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上消化道疾病患者幽门螺杆菌的细胞毒素产生情况。

Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.

作者信息

Tee W, Lambert J R, Dwyer B

机构信息

Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Australia.

出版信息

J Clin Microbiol. 1995 May;33(5):1203-5. doi: 10.1128/jcm.33.5.1203-1205.1995.

DOI:10.1128/jcm.33.5.1203-1205.1995
PMID:7615729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC228131/
Abstract

A cytotoxin produced by some Helicobacter pylori strains has recently been identified. The cytotoxin induces intracellular vacuolization of cultured cells. The aim of the present study was to examine the frequency of occurrence of cytotoxin-producing strains of H. pylori from subjects with upper gastrointestinal disease including nonulcer dyspepsia, gastric and duodenal ulcer disease, gastroesophageal reflux disease, and gastric cancer. Broth culture filtrates of clinical isolates of H. pylori recovered from 175 patients were used to inoculate Vero and HeLa cell monolayers for the detection of vacuolating cytotoxin activity. The results obtained demonstrated that the highest percentage of strains producing cytotoxin were found in subjects with peptic ulcer disease (gastric ulcer, 65%; duodenal ulcer, 66%; P < 0.01 compared with nonulcer dyspepsia, 38%). Of the 11 patients with gastroesophageal reflux disease, 4 of 5 patients in this group who had esophageal ulcers, were found to be infected with strains that produced cytotoxin. Three of the four patients with carcinoma of the stomach were also found to be infected with cytotoxic strains of H. pylori. With increasing severity of mucosal damage in subjects with a normal upper gastrointestinal tract, macroscopic gastritis, duodenitis, and peptic ulceration, there were corresponding increase in the proportion of strains producing cytotoxin; these increases were 32, 46, 50, and 66%, respectively. H. pylori strains from subjects with ulcer disease commonly produced vacuolating cytotoxin, suggesting that it may be a virulence factor in the pathogenesis of peptic ulcer disease.

摘要

最近已鉴定出某些幽门螺杆菌菌株产生的一种细胞毒素。该细胞毒素可诱导培养细胞发生细胞内空泡化。本研究的目的是检测上消化道疾病患者,包括非溃疡性消化不良、胃溃疡和十二指肠溃疡疾病、胃食管反流病以及胃癌患者中,产细胞毒素幽门螺杆菌菌株的出现频率。从175例患者中分离得到的幽门螺杆菌临床菌株的肉汤培养滤液,用于接种Vero和HeLa细胞单层,以检测空泡化细胞毒素活性。所得结果表明,产细胞毒素菌株比例最高的是消化性溃疡疾病患者(胃溃疡,65%;十二指肠溃疡,66%;与非溃疡性消化不良患者的38%相比,P<0.01)。在11例胃食管反流病患者中,该组5例患有食管溃疡的患者中有4例被发现感染了产细胞毒素的菌株。4例胃癌患者中有3例也被发现感染了幽门螺杆菌细胞毒素菌株。在上消化道正常的患者中,随着黏膜损伤严重程度的增加,即从宏观胃炎、十二指肠炎到消化性溃疡,产细胞毒素菌株的比例相应增加;这些增加分别为32%、46%、50%和66%。溃疡疾病患者的幽门螺杆菌菌株通常产生空泡化细胞毒素,这表明它可能是消化性溃疡疾病发病机制中的一种毒力因子。

相似文献

1
Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.上消化道疾病患者幽门螺杆菌的细胞毒素产生情况。
J Clin Microbiol. 1995 May;33(5):1203-5. doi: 10.1128/jcm.33.5.1203-1205.1995.
2
Vacuolating cytotoxic activity of 40 Helicobacter pylori strains isolated from Turkish patients.从土耳其患者中分离出的40株幽门螺杆菌的空泡细胞毒性活性。
APMIS. 2000 Apr;108(4):293-5. doi: 10.1034/j.1600-0463.2000.d01-59.x.
3
Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia.对167株来自消化性溃疡或非溃疡性消化不良患者的分离菌株中CagA和VacA的表达及空泡形成活性进行分析。
Am J Gastroenterol. 1998 Jan;93(1):30-4. doi: 10.1111/j.1572-0241.1998.030_c.x.
4
[Helicobacter pylori and gastrointestinal tract diseases].[幽门螺杆菌与胃肠道疾病]
Tidsskr Nor Laegeforen. 1992 Aug 10;112(18):2353-5.
5
Cytotoxic isolates of Helicobacter pylori from peptic ulcer diseases decrease K+-dependent ATPase activity in HeLa cells.来自消化性溃疡疾病患者的幽门螺杆菌细胞毒性分离株可降低HeLa细胞中钾离子依赖性ATP酶的活性。
BMC Gastroenterol. 2003 Nov 6;3:31. doi: 10.1186/1471-230X-3-31.
6
Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients.来自消化性溃疡、萎缩性胃炎和胃癌患者的幽门螺杆菌分离株产生空泡毒素的情况。
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S29-31.
7
In vitro cytotoxic effects of vacuolating cytotoxin produced by clinical isolates of Helicobacter pylori.幽门螺杆菌临床分离株产生的空泡毒素的体外细胞毒性作用
Kansenshogaku Zasshi. 1998 Oct;72(10):1027-34. doi: 10.11150/kansenshogakuzasshi1970.72.1027.
8
Expression of vacuolating cytotoxin in clinical isolates of Helicobacter pylori.幽门螺杆菌临床分离株中空泡毒素的表达
J Gastroenterol. 1996 Nov;31 Suppl 9:9-11.
9
Detection and characterization of Helicobacter pylori from patients with gastroduodenal diseases.胃十二指肠疾病患者幽门螺杆菌的检测与特征分析。
Diagn Microbiol Infect Dis. 1998 Aug;31(4):531-6. doi: 10.1016/s0732-8893(98)00055-8.
10
Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.从消化性溃疡和慢性胃炎患者中分离出的幽门螺杆菌菌株产生细胞毒素与中性粒细胞激活的相关性。
Gut. 1996 Jun;38(6):841-5. doi: 10.1136/gut.38.6.841.

引用本文的文献

1
Mucosal Adhesive Chitosan Nanogel Formulations of Antibiotics and Adjuvants (Terpenoids, Flavonoids, etc.) and Their Potential for the Treatment of Infectious Diseases of the Gastrointestinal Tract.抗生素与佐剂(萜类、黄酮类等)的黏膜黏附性壳聚糖纳米凝胶制剂及其治疗胃肠道传染病的潜力
Pharmaceutics. 2023 Sep 20;15(9):2353. doi: 10.3390/pharmaceutics15092353.
2
Astaxanthin Inhibits Matrix Metalloproteinase Expression by Suppressing PI3K/AKT/mTOR Activation in -Infected Gastric Epithelial Cells.虾青素通过抑制 PI3K/AKT/mTOR 激活抑制 - 感染胃上皮细胞中基质金属蛋白酶的表达。
Nutrients. 2022 Aug 20;14(16):3427. doi: 10.3390/nu14163427.
3
Occurrence of cagA vacA s1a m1 i1 Helicobacter pylori in farm animals in Egypt and ability to survive in experimentally contaminated UHT milk.埃及农场动物中 cagA vacA s1a m1 i1 幽门螺杆菌的发生及其在实验性污染 UHT 奶中存活的能力。
Sci Rep. 2018 Sep 24;8(1):14260. doi: 10.1038/s41598-018-32671-0.
4
Protein Targets of Frankincense: A Reverse Docking Analysis of Terpenoids from Oleo-Gum Resins.乳香的蛋白质靶点:对油胶树脂中萜类化合物的反向对接分析
Medicines (Basel). 2018 Aug 31;5(3):96. doi: 10.3390/medicines5030096.
5
A systematic review on the association between the Helicobacter pylori vacA i genotype and gastric disease.关于幽门螺杆菌vacA i基因型与胃部疾病关联的系统评价。
FEBS Open Bio. 2016 Apr 5;6(5):409-17. doi: 10.1002/2211-5463.12046. eCollection 2016 May.
6
Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases.伊朗的幽门螺杆菌:关于基因型与胃十二指肠疾病关联的系统评价
J Res Med Sci. 2012 Mar;17(3):280-92.
7
Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in Pakistan.巴基斯坦胃十二指肠疾病患者中幽门螺杆菌毒力标志物的分布。
BMC Gastroenterol. 2009 Nov 20;9:87. doi: 10.1186/1471-230X-9-87.
8
Helicobacter pylori and gastroesophageal reflux disease.幽门螺杆菌与胃食管反流病
World J Surg Oncol. 2008 Jul 5;6:74. doi: 10.1186/1477-7819-6-74.
9
Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.土耳其十二指肠溃疡患者血清中抗幽门螺杆菌空泡毒素A(VacA)和细胞毒素相关蛋白A(CagA)抗原抗体谱分析。
World J Gastroenterol. 2006 Nov 14;12(42):6869-73. doi: 10.3748/wjg.v12.i42.6869.
10
H pylori and host interactions that influence pathogenesis.幽门螺杆菌与影响发病机制的宿主相互作用。
World J Gastroenterol. 2006 Sep 21;12(35):5599-605. doi: 10.3748/wjg.v12.i35.5599.

本文引用的文献

1
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.与细胞毒性和十二指肠溃疡相关的幽门螺杆菌128-kDa免疫显性抗原的分子特征
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5791-5. doi: 10.1073/pnas.90.12.5791.
2
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.幽门螺杆菌一种高分子量主要抗原的克隆与表达:与细胞毒素产生相关的证据
Infect Immun. 1993 May;61(5):1799-809. doi: 10.1128/iai.61.5.1799-1809.1993.
3
Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin.ATP酶抑制剂对人宫颈癌HeLa细胞对幽门螺杆菌空泡毒素反应的影响。
Infect Immun. 1993 Apr;61(4):1427-31. doi: 10.1128/iai.61.4.1427-1431.1993.
4
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer.胃癌中对幽门螺杆菌的全身和黏膜体液反应。
Gut. 1993 Oct;34(10):1339-43. doi: 10.1136/gut.34.10.1339.
5
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo.幽门螺杆菌分离株在体外和体内产生空泡毒素之间的相关性。
Infect Immun. 1993 Dec;61(12):5008-12. doi: 10.1128/iai.61.12.5008-5012.1993.
6
Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.幽门螺杆菌肉汤培养滤液中的细胞毒性活性。
J Med Microbiol. 1988 Jun;26(2):93-9. doi: 10.1099/00222615-26-2-93.
7
Characterization of urease from Campylobacter pylori.幽门螺杆菌脲酶的特性分析
J Clin Microbiol. 1988 May;26(5):831-6. doi: 10.1128/jcm.26.5.831-836.1988.
8
Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.仅从消化性溃疡患者和慢性胃炎患者中分离出的幽门螺杆菌菌株产生细胞毒素的情况。
J Clin Microbiol. 1989 Jan;27(1):225-6. doi: 10.1128/jcm.27.1.225-226.1989.
9
Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms.
Am J Clin Pathol. 1986 Nov;86(5):575-82. doi: 10.1093/ajcp/86.5.575.
10
Antibody to cytotoxin in infection by Helicobacter pylori.幽门螺杆菌感染中细胞毒素抗体
J Clin Microbiol. 1990 Jun;28(6):1181-4. doi: 10.1128/jcm.28.6.1181-1184.1990.